Prevention of Neutropenia from Cancer Chemotherapy
Neutropenia is a significant and potentially life-threatening complication of cancer chemotherapy, characterized by a reduction in absolute neutrophil count (ANC), thereby compromising the body’s ability to combat infections. The condition is most commonly observed within 7 to 14 days after cytotoxic treatment, with severity classified as: If neutropenia is accompanied by fever (≥38.3°C once or